Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (221-230 of 503) with videos related to

Pageof 51
Sort By:
Annals of Emergency Medicine|January 17, 2025
ECG Patterns of Occlusion Myocardial Infarction: A Narrative ReviewFabrizio Ricci, Chiara Martini, Davide Maria Scordo, et al.
Elife|December 16, 2014
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemiaJiguang Wang, Hossein Khiabanian, Davide Rossi, et al.
Hemasphere|August 11, 2025
Working towards harmonization of clinical trial reporting in Hodgkin lymphomaCarsten Kobe, Philippe Armand, Sven Borchmann, et al.
Annals of Hematology|July 17, 2024
Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expressionMax J Rieger, Thomas Pabst, Barbara Jeker, et al.
Hematological Oncology|March 19, 2011
In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomasAndrea Rinaldi, Maurilio Ponzoni, Silvia Uccella, et al.
Journal of the National Cancer Institute|January 5, 2002
Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphomaManel Esteller, Gianluca Gaidano, Steven N Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractorinessDavide Rossi, Michaela Cerri, Clara Deambrogi, et al.
Hematological Oncology|June 15, 2011
Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotypeMichael Mian, Andrea Rinaldi, Afua Adjeiwaa Mensah, et al.
Clinical Rehabilitation|June 14, 2017
A comparative study on assessment procedures and metric properties of two scoring systems of the Coma Recovery Scale-Revised items: standard and modified scoresDavide Sattin, Piergiorgio Lovaglio, Greta Brenna, et al.
Critical Reviews in Oncology/Hematology|June 24, 2010
Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experiencePiero Stratta, Luciana Gravellone, Tiziana Cena, et al.
Pageof 51

Showing results (221-230 of 503) with videos related to

Sort By:
Pageof 51
Annals of Emergency Medicine|January 17, 2025
ECG Patterns of Occlusion Myocardial Infarction: A Narrative ReviewFabrizio Ricci, Chiara Martini, Davide Maria Scordo, et al.
Elife|December 16, 2014
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemiaJiguang Wang, Hossein Khiabanian, Davide Rossi, et al.
Hemasphere|August 11, 2025
Working towards harmonization of clinical trial reporting in Hodgkin lymphomaCarsten Kobe, Philippe Armand, Sven Borchmann, et al.
Annals of Hematology|July 17, 2024
Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expressionMax J Rieger, Thomas Pabst, Barbara Jeker, et al.
Hematological Oncology|March 19, 2011
In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomasAndrea Rinaldi, Maurilio Ponzoni, Silvia Uccella, et al.
Journal of the National Cancer Institute|January 5, 2002
Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphomaManel Esteller, Gianluca Gaidano, Steven N Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractorinessDavide Rossi, Michaela Cerri, Clara Deambrogi, et al.
Hematological Oncology|June 15, 2011
Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotypeMichael Mian, Andrea Rinaldi, Afua Adjeiwaa Mensah, et al.
Clinical Rehabilitation|June 14, 2017
A comparative study on assessment procedures and metric properties of two scoring systems of the Coma Recovery Scale-Revised items: standard and modified scoresDavide Sattin, Piergiorgio Lovaglio, Greta Brenna, et al.
Critical Reviews in Oncology/Hematology|June 24, 2010
Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experiencePiero Stratta, Luciana Gravellone, Tiziana Cena, et al.
Pageof 51